A 62-year-old woman from Delhi with a 15-year history of rheumatoid arthritis presents with progressive renal dysfunction. Serum creatinine is 2.8 mg/dL, 24-hour urine protein is 4.2 g/day, and urinalysis shows nephrotic-range proteinuria. Renal biopsy shows Congo red-positive deposits in the glomeruli and blood vessel walls with apple-green birefringence. Immunofluorescence microscopy is negative for immunoglobulin and complement deposition. What is the most likely diagnosis?

Explanation

## Clinical Context & Pathology Integration This patient has **secondary amyloidosis (AA amyloidosis)** complicating long-standing rheumatoid arthritis. The Congo red staining with apple-green birefringence confirms amyloid; the negative immunofluorescence excludes immunoglobulin-based disease. ## AA Amyloidosis: Secondary Amyloidosis **Key Point:** AA amyloidosis is the second most common form of systemic amyloidosis and arises from chronic inflammatory conditions. It is composed of serum amyloid A (SAA), an acute-phase reactant produced during chronic inflammation. ### Pathogenesis 1. Chronic inflammatory state → persistent elevation of SAA 2. Misfolding and aggregation of SAA → amyloid fibril formation 3. Deposition in kidneys (glomeruli, blood vessels), liver, spleen, GI tract ### Clinical Features of AA Amyloidosis - **Primary organs affected:** Kidneys (most common), liver, spleen - **Renal presentation:** Nephrotic syndrome, progressive renal failure - **Immunofluorescence:** Negative (no immunoglobulin/complement) — distinguishes from immune-complex GN - **Associated conditions:** Chronic infections (TB, osteomyelitis), rheumatoid arthritis, inflammatory bowel disease, Familial Mediterranean Fever (FMF) ### Why This Is AA, Not AL | Feature | AA Amyloidosis | AL Amyloidosis | | --- | --- | --- | | **Underlying disease** | Chronic inflammation (RA, TB, IBD) | Plasma cell dyscrasia (occult or overt) | | **Organ involvement** | Kidney >> liver, spleen | Heart >> kidney, liver | | **Cardiac involvement** | Rare | Common (restrictive cardiomyopathy) | | **Immunofluorescence** | Negative | Negative (but light chains may be detected by mass spec) | | **Prognosis** | Better if underlying inflammation controlled | Poor without treatment | | **Treatment** | Control inflammation (DMARDs, biologics) | Chemotherapy, stem cell transplant | **Clinical Pearl:** The **negative immunofluorescence** is crucial — it excludes immune-complex glomerulonephritis and light chain deposition disease (LCDD), both of which would show positive immunofluorescence. **High-Yield:** **Chronic inflammation + nephrotic syndrome + Congo red positive + negative immunofluorescence = AA amyloidosis.** The 15-year history of RA is the key clinical clue. ## Mermaid: Amyloidosis Classification ```mermaid flowchart TD A[Systemic Amyloidosis]:::outcome --> B{Underlying Cause?}:::decision B -->|Plasma cell dyscrasia| C[AL Amyloidosis]:::outcome C --> C1[Light chain: κ or λ] B -->|Chronic inflammation| D[AA Amyloidosis]:::outcome D --> D1[Serum Amyloid A] B -->|Dialysis| E[AβM Amyloidosis]:::outcome E --> E1[β2-microglobulin] B -->|Genetic: TTR mutation| F[ATTR Amyloidosis]:::outcome F --> F1[Hereditary or wild-type] D1 --> D2[Organs: kidney >> liver, spleen] C1 --> C2[Organs: heart >> kidney, liver] ```